title: CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1.
abstract: Hematopoietic stem cell transplantation (HSCT) is an important treatment option for patients with malignant and nonmalignant hematologic diseases. Methods to improve transplant efficiency are being explored with the intent to improve engraftment and immune reconstitution post-HSCT. A current approach under investigation involves treatment of donor cells with inhibitors that target the protease CD26, a negative regulator of the chemokine CXCL12/stromal cell-derived factor-1. CD26 inhibitor treatment has been shown to improve the functional response of CD34(+) cord blood (CB) cells, but not CD34(+) granulocyte colony-stimulating factor-mobilized peripheral blood stem cells, to CXCL12/stromal cell-derived factor-1. The effect of CD26 inhibitors on unfractionated CB, bone marrow, or granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells has not been evaluated previously. We observed that although CB had greater CD26 expression than bone marrow or mobilized peripheral blood, treatment with a CD26 inhibitor (Diprotin A) resulted in increased responsiveness to stromal cell-derived factor-1 for all three mononuclear cell sources tested. This suggests that clinical therapeutic benefit might be gained by using CD26 inhibitors as a strategy to improve engraftment of unfractionated mobilized peripheral blood cells as well as CB cells.
authors: Section of Hematology and Section of Bone Marrow Transplant and Cell Therapy, Division of Hematology/Oncology/Cell Therapy, Rush University Medical Center, Chicago, IL 60612, USA. Kent_Christopherson@rush.edu
authors: Kent W
authors: KW
authors: Christopherson
authors: Robin R
authors: RR
authors: Frank
authors: Sucheta
authors: S
authors: Jagan
authors: Laura A
authors: LA
authors: Paganessi
authors: Stephanie A
authors: SA
authors: Gregory
authors: Henry C
authors: HC
authors: Fung
mesh_terms: D015153:Blotting, Western; D001853:Bone Marrow / Q000502:physiology*; D002448:Cell Adhesion; D002465:Cell Movement; D054377:Chemokine CXCL12 / Q000502:physiology*; D018819:Dipeptidyl Peptidase 4 / Q000187:drug effects*; D005312:Fetal Blood / Q000502:physiology*; D005434:Flow Cytometry; D006801:Humans; D011480:Protease Inhibitors / Q000494:pharmacology*
chemical_list: C515255:CXCL12 protein, human; D054377:Chemokine CXCL12; D011480:Protease Inhibitors; D018819:Dipeptidyl Peptidase 4